Registry of Asthma Characterization and Recruitment 3 (RACR3)

Launched by NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) · Feb 28, 2022

Keywords

ClinConnect Summary

The Registry of Asthma Characterization and Recruitment 3 (RACR3) is a study designed to gather information about asthma in people living in urban areas. This registry will help researchers recruit participants for future studies focused on childhood asthma. The goal is to create a database that can support ongoing research to better understand and manage asthma in children and adults.

To be eligible for this study, you need to be at least 18 years old and able to give your consent, or if you are under 18, you must be with a legal guardian who can provide consent. You should also live in a specific urban area. Participants need to be comfortable speaking English or Spanish and have regular access to a phone for follow-up calls. If you are pregnant or breastfeeding, you can still take part in the study, but certain tests will not be performed during your pregnancy. As a participant, you can expect to help researchers gather valuable information that could lead to better treatments for asthma in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• 1. Participant is either:
• • 1. At least 18 years old, willing and able to provide informed consent at the time of enrollment
• • 2. Under the age of 18, accompanied by a legal guardian who is willing and able to provide informed consent at the time of enrollment
• • 2. Participant has a primary place of residence within the Office of Management and Budget (OMB)-defined Metropolitan Statistical Area (MSA)
• Exclusion Criteria:
• • 1. Participant does not speak English or Spanish and/or guardian does not speak English or Spanish
• • 2. Participant does not have access to a phone, either personal or public, with regularity that could be used for scheduling and safety follow-up
• • 3. Past or current medical problems or findings from physical examination or laboratory testing, which, in the opinion of the investigator, may pose additional risks from participation in the study, may interfere with the participant's ability to comply with study requirements or that may affect the quality or interpretation of the data obtained from the study
• • Participants who are pregnant or lactating will not be excluded or discontinued from the study, but will not undergo any procedures that are prohibited during pregnancy per the Childhood Asthma in Urban Settings 02 (CAUSE-02) Registry for Asthma Characterization and Recruitment 3 (RACR3) Manual of Procedures (MOP)(e.g., allergen skin testing, spirometry) during the pregnancy.
• • Potential participants may be reassessed as outlined in the Protocol CAUSE-02 MOP.